Login / Signup
Bradford A Perez
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 2
Top Topics
Pseudomonas Aeruginosa
Poor Prognosis
Cystic Fibrosis
Regulatory T Cells
Top Venues
Molecular cancer therapeutics
Cancer immunology research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Hong Zheng
,
Xiaoqing Yu
,
Mohammed L Ibrahim
,
Dana Foresman
,
Mengyu Xie
,
Joseph O Johnson
,
Theresa A Boyle
,
Brian H Ruffell
,
Bradford A Perez
,
Scott J Antonia
,
Neal E Ready
,
Andreas N Saltos
,
Mark J Cantwell
,
Amer A Beg
Combination IFNβ and membrane-stable CD40L maximize tumor dendritic cell activation and lymph node trafficking to elicit systemic T-cell immunity.
Cancer immunology research
(2023)
Alexandra L Martin
,
Carmen M Anadon
,
Subir Biswas
,
Jessica A Mine
,
Katelyn F Handley
,
Kyle K Payne
,
Gunjan Mandal
,
Ricardo A Chaurio
,
Joseph Pidala
,
Kimberly B Sprenger
,
Kristen E Rigolizzo
,
Patrick Innamarato
,
Carly M Harro
,
Sumit Mehta
,
Bradford A Perez
,
Robert M Wenham
,
José R Conejo-Garcia
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors.
Molecular cancer therapeutics
21 (7) (2022)